文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

前列腺癌细胞分泌的胰岛素样生长因子-I在体外或体内均不会改变肿瘤与骨细胞的相互作用。

IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo.

作者信息

Rubin Janet, Fan Xian, Rahnert Jill, Sen Buer, Hsieh Chia-Ling, Murphy Tamara C, Nanes Mark S, Horton Lindsay G, Beamer Wesley G, Rosen Clifford J

机构信息

Department of Medicine, Emory University & VAMC, Decatur, Georgia.

出版信息

Prostate. 2006 Jun 1;66(8):789-800. doi: 10.1002/pros.20379.


DOI:10.1002/pros.20379
PMID:16482567
Abstract

BACKGROUND: IGF-I is an important growth and differentiative factor for osteoblasts and may have a role in defining prostate cancer risk and skeletal metastases. METHODS: Conditioned media (CM) from human prostate cancer (PC), C4-2 and C4-2B, which produce osteoblastic lesions, and PC-3, which causes osteolysis, was added to MC3T3-E1 bone cultures. SCID mice were injected intratibially with these engineered cells. Tumor bearing tibiae were analyzed by microCT and pQCT. RESULTS: CM from PC cells increased osteoblast proliferation and differentiation and was unaltered by the type of PC cell, IGF-I antibodies, or exogenous IGF-I and IGFBP2. Study of intratibial PC tumors in SCID mice showed that C4-2 cells grew slowly preserving bone structure, while PC-3 tumors caused rapid osteolysis. Overexpression of IGF-I did not change either tumor progression or skeletal response. CONCLUSIONS: IGF-I is neither necessary nor sufficient for the osteoblastic response to PC metastases.

摘要

背景:胰岛素样生长因子-I(IGF-I)是成骨细胞重要的生长和分化因子,可能在前列腺癌风险及骨转移的判定中发挥作用。 方法:将来自产生成骨病变的人前列腺癌(PC)细胞系C4-2和C4-2B以及导致骨质溶解的PC-3细胞系的条件培养基(CM)添加到MC3T3-E1骨培养物中。将这些经过工程改造的细胞经胫骨内注射到重症联合免疫缺陷(SCID)小鼠体内。通过显微计算机断层扫描(microCT)和外周定量计算机断层扫描(pQCT)对荷瘤胫骨进行分析。 结果:PC细胞系的CM可增加成骨细胞的增殖和分化,且不受PC细胞类型、IGF-I抗体或外源性IGF-I和胰岛素样生长因子结合蛋白2(IGFBP2)的影响。对SCID小鼠胫骨内PC肿瘤的研究表明,C4-2细胞生长缓慢,可保留骨结构,而PC-3肿瘤则导致快速骨质溶解。IGF-I的过表达既未改变肿瘤进展,也未改变骨骼反应。 结论:IGF-I对于PC转移的成骨反应既非必需,也不充分。

相似文献

[1]
IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo.

Prostate. 2006-6-1

[2]
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.

Clin Cancer Res. 2003-7

[3]
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.

Cancer Res. 2005-12-1

[4]
Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.

Prostate. 2004-1-1

[5]
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

Bone. 2006-2

[6]
Osteoprotegerin in prostate cancer bone metastasis.

Cancer Res. 2005-3-1

[7]
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.

Oncol Res. 1997

[8]
Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.

Cancer Res. 2004-9-1

[9]
Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.

Prostate. 2009-8-1

[10]
RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.

Prostate. 2008-1-1

引用本文的文献

[1]
Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast.

Bone. 2015-6

[2]
Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model.

Lab Invest. 2013-1-28

[3]
Steps in prostate cancer progression that lead to bone metastasis.

Int J Cancer. 2011-3-28

[4]
Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCaP human prostate cancer cells.

Am J Transl Res. 2010-3-6

[5]
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.

J Clin Invest. 2008-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索